P AMY AY3855

GUDID 05055273200614

A Pancreatic α‑Amylase test system is a device intended for the quantitative in vitro determination of Pancreatic α‑Amylase activity in serum, plasma

RANDOX LABORATORIES LIMITED

Amylase isoenzyme IVD, reagent
Primary Device ID05055273200614
NIH Device Record Key8a7dc279-badb-4237-a3f5-b242cc63be38
Commercial Distribution StatusIn Commercial Distribution
Brand NameP AMY
Version Model NumberAY3855
Catalog NumberAY3855
Company DUNS227530649
Company NameRANDOX LABORATORIES LIMITED
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone+442894451070
Emailtechnical.services@randox.com

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS105055273200614 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

JFJCatalytic Methods, Amylase

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number3
Public Version Date2018-07-06
Device Publish Date2016-09-09

On-Brand Devices [P AMY]

05055273200669The device is intended for the quantitative in vitro determination of pancreatic α amylase in s
05055273200614A Pancreatic α‑Amylase test system is a device intended for the quantitative in vitro determi
05055273200591A Pancreatic α‑Amylase test system is a device intended for the quantitative in vitro determi

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.